A National Survey of Physicians' Views on the Importance and Implementation of Deintensifying Diabetes Medications
© 2023. The Author(s), under exclusive licence to Society of General Internal Medicine..
BACKGROUND: Guidelines recommend deintensifying hypoglycemia-causing medications for older adults with diabetes whose hemoglobin A1c is below their individualized target, but this rarely occurs in practice.
OBJECTIVE: To understand physicians' decision-making around deintensifying diabetes treatment.
DESIGN: National physician survey.
PARTICIPANTS: US physicians in general medicine, geriatrics, or endocrinology providing outpatient diabetes care.
MAIN MEASURES: Physicians rated the importance of deintensifying diabetes medications for older adults with type 2 diabetes, and of switching medication classes, on 5-point Likert scales. They reported the frequency of these actions for their patients, and listed important barriers and facilitators. We evaluated the independent association between physicians' professional and practice characteristics and the importance of deintensifying and switching diabetes medications using multivariable ordered logistic regression models.
KEY RESULTS: There were 445 eligible respondents (response rate 37.5%). The majority of physicians viewed deintensifying (80%) and switching (92%) diabetes medications as important or very important to the care of older adults. Despite this, one-third of physicians reported deintensifying diabetes medications rarely or never. While most physicians recognized multiple reasons to deintensify, two-thirds of physicians reported barriers of short-term hyperglycemia and patient reluctance to change medications or allow higher glucose levels. In multivariable models, geriatricians rated deintensification as more important compared to other specialties (p=0.027), and endocrinologists rated switching as more important compared to other specialties (p<0.006). Physicians with fewer years in practice rated higher importance of deintensification (p<0.001) and switching (p=0.003).
CONCLUSIONS: While most US physicians viewed deintensifying and switching diabetes medications as important for the care of older adults, they deintensified infrequently. Physicians had ambivalence about the relative benefits and harms of deintensification and viewed it as a potential source of conflict with their patients. These factors likely contribute to clinical inertia, and studies focused on improving shared decision-making around deintensifying diabetes medications are needed.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2023 |
|---|---|
| Enthalten in: |
Journal of general internal medicine - (2023) vom: 08. Nov. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Pilla, Scott J [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Aging |
|---|
| Anmerkungen: |
Date Revised 05.03.2024 published: Print-Electronic Citation Status Publisher |
|---|
| doi: |
10.1007/s11606-023-08506-8 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM364324937 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM364324937 | ||
| 003 | DE-627 | ||
| 005 | 20240305232028.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s11606-023-08506-8 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1317.xml |
| 035 | |a (DE-627)NLM364324937 | ||
| 035 | |a (NLM)37940754 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Pilla, Scott J |e verfasserin |4 aut | |
| 245 | 1 | 2 | |a A National Survey of Physicians' Views on the Importance and Implementation of Deintensifying Diabetes Medications |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 05.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status Publisher | ||
| 520 | |a © 2023. The Author(s), under exclusive licence to Society of General Internal Medicine. | ||
| 520 | |a BACKGROUND: Guidelines recommend deintensifying hypoglycemia-causing medications for older adults with diabetes whose hemoglobin A1c is below their individualized target, but this rarely occurs in practice | ||
| 520 | |a OBJECTIVE: To understand physicians' decision-making around deintensifying diabetes treatment | ||
| 520 | |a DESIGN: National physician survey | ||
| 520 | |a PARTICIPANTS: US physicians in general medicine, geriatrics, or endocrinology providing outpatient diabetes care | ||
| 520 | |a MAIN MEASURES: Physicians rated the importance of deintensifying diabetes medications for older adults with type 2 diabetes, and of switching medication classes, on 5-point Likert scales. They reported the frequency of these actions for their patients, and listed important barriers and facilitators. We evaluated the independent association between physicians' professional and practice characteristics and the importance of deintensifying and switching diabetes medications using multivariable ordered logistic regression models | ||
| 520 | |a KEY RESULTS: There were 445 eligible respondents (response rate 37.5%). The majority of physicians viewed deintensifying (80%) and switching (92%) diabetes medications as important or very important to the care of older adults. Despite this, one-third of physicians reported deintensifying diabetes medications rarely or never. While most physicians recognized multiple reasons to deintensify, two-thirds of physicians reported barriers of short-term hyperglycemia and patient reluctance to change medications or allow higher glucose levels. In multivariable models, geriatricians rated deintensification as more important compared to other specialties (p=0.027), and endocrinologists rated switching as more important compared to other specialties (p<0.006). Physicians with fewer years in practice rated higher importance of deintensification (p<0.001) and switching (p=0.003) | ||
| 520 | |a CONCLUSIONS: While most US physicians viewed deintensifying and switching diabetes medications as important for the care of older adults, they deintensified infrequently. Physicians had ambivalence about the relative benefits and harms of deintensification and viewed it as a potential source of conflict with their patients. These factors likely contribute to clinical inertia, and studies focused on improving shared decision-making around deintensifying diabetes medications are needed | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a aging | |
| 650 | 4 | |a deprescriptions | |
| 650 | 4 | |a diabetes mellitus, type 2 | |
| 650 | 4 | |a drug-related side effects and adverse reactions | |
| 650 | 4 | |a hypoglycemia | |
| 700 | 1 | |a Jalalzai, Rabia |e verfasserin |4 aut | |
| 700 | 1 | |a Tang, Olive |e verfasserin |4 aut | |
| 700 | 1 | |a Schoenborn, Nancy L |e verfasserin |4 aut | |
| 700 | 1 | |a Boyd, Cynthia M |e verfasserin |4 aut | |
| 700 | 1 | |a Bancks, Michael P |e verfasserin |4 aut | |
| 700 | 1 | |a Mathioudakis, Nestoras N |e verfasserin |4 aut | |
| 700 | 1 | |a Maruthur, Nisa M |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of general internal medicine |d 1986 |g (2023) vom: 08. Nov. |w (DE-627)NLM01293612X |x 1525-1497 |7 nnns |
| 773 | 1 | 8 | |g year:2023 |g day:08 |g month:11 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s11606-023-08506-8 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |j 2023 |b 08 |c 11 | ||